| Product Code: ETC9974378 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Precision Medicine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Precision Medicine Market - Industry Life Cycle |
3.4 United States (US) Precision Medicine Market - Porter's Five Forces |
3.5 United States (US) Precision Medicine Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.6 United States (US) Precision Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of personalized medicine approaches in healthcare |
4.2.2 Technological advancements in genomics and molecular diagnostics |
4.2.3 Rising prevalence of chronic diseases and cancer |
4.2.4 Supportive government initiatives and funding for precision medicine research |
4.3 Market Restraints |
4.3.1 High costs associated with precision medicine treatments |
4.3.2 Complex regulatory landscape for approval of personalized therapies |
4.3.3 Limited reimbursement policies for precision medicine procedures |
4.3.4 Data privacy and security concerns related to personalized healthcare data |
5 United States (US) Precision Medicine Market Trends |
6 United States (US) Precision Medicine Market, By Types |
6.1 United States (US) Precision Medicine Market, By End-Use |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Precision Medicine Market Revenues & Volume, By End-Use, 2021- 2031F |
6.1.3 United States (US) Precision Medicine Market Revenues & Volume, By Home Care, 2021- 2031F |
6.1.4 United States (US) Precision Medicine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.1.5 United States (US) Precision Medicine Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.1.6 United States (US) Precision Medicine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Precision Medicine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Precision Medicine Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.2.3 United States (US) Precision Medicine Market Revenues & Volume, By Therapeutics, 2021- 2031F |
7 United States (US) Precision Medicine Market Import-Export Trade Statistics |
7.1 United States (US) Precision Medicine Market Export to Major Countries |
7.2 United States (US) Precision Medicine Market Imports from Major Countries |
8 United States (US) Precision Medicine Market Key Performance Indicators |
8.1 Number of clinical trials incorporating precision medicine approaches |
8.2 Adoption rate of precision medicine techniques by healthcare providers |
8.3 Patient outcomes and survival rates following precision medicine interventions |
8.4 Investment and funding trends in precision medicine research and development |
8.5 Rate of integration of genomic data into clinical decision-making processes |
9 United States (US) Precision Medicine Market - Opportunity Assessment |
9.1 United States (US) Precision Medicine Market Opportunity Assessment, By End-Use, 2021 & 2031F |
9.2 United States (US) Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Precision Medicine Market - Competitive Landscape |
10.1 United States (US) Precision Medicine Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here